↓ Skip to main content

QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study

Overview of attention for article published in BMC Infectious Diseases, December 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study
Published in
BMC Infectious Diseases, December 2014
DOI 10.1186/s12879-014-0654-5
Pubmed ID
Authors

Mulugeta Belay, Mengistu Legesse, Daniel Dagne, Adane Mihret, Yonas Bekele, Girmay Medhin, Gunnar Bjune, Fekadu Abebe

Abstract

BackgroundQuantiFERON-TB Gold In-Tube® (QFT) test is used for the diagnosis of latent tuberculosis (TB) infection. Besides, QFT test could allow tracking changes in immune response among TB patients and their contacts. In high TB burden settings, reports on QFT conversions and reversions among TB patients and their contacts are limited. As part of a major project to study immune responses to TB infection, we investigated QFT test conversions and reversions among smear positive pulmonary TB patients and their household contacts over 12 months.MethodsWe followed a total of 107 HIV negative participants (33 patients and 74 contacts) in Addis Ababa. We did QFT test at baseline and 12 months later according to the manufacturer¿s instructions.ResultsAt baseline, 25/33 (75.8%) of the patients and 50/74 (67.6%) of the contacts were QFT positive. At 12 months, 2 more patients (1 test negative and 1 indeterminate) became test positive. Besides, 11/24 (45.8%) test negative contacts became positive. Only one patient and one contact who were test positive at baseline became test negative 12 months later. At 12 months, the proportions of test positives for patients and contacts were, therefore, 78.8% and 81.1%, respectively. Among contacts, the proportion of test positives at 12 months was significantly higher compared to the proportion at baseline (McNemar, p¿=¿0.006); similarly, the median IFN-¿ response significantly increased at 12 months compared with the baseline level (Wilcoxon matched-pairs signed rank test, p¿=¿0.01). Patients, however, had comparable median IFN-¿ levels at baseline and 12 months later (p¿=¿0.56).ConclusionNearly half of QFT negative household contacts at baseline became positive at 12 months. This suggests that repeated screening of QFT negative contacts may be needed for epidemiological studies and interventions of latent TB in an endemic setting. A large longitudinal study may be needed to confirm our observations.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Master 7 14%
Student > Ph. D. Student 7 14%
Student > Doctoral Student 3 6%
Other 3 6%
Other 7 14%
Unknown 13 26%
Readers by discipline Count As %
Medicine and Dentistry 18 36%
Nursing and Health Professions 4 8%
Immunology and Microbiology 4 8%
Biochemistry, Genetics and Molecular Biology 2 4%
Social Sciences 2 4%
Other 3 6%
Unknown 17 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2014.
All research outputs
#20,245,139
of 22,772,779 outputs
Outputs from BMC Infectious Diseases
#6,459
of 7,668 outputs
Outputs of similar age
#302,268
of 360,895 outputs
Outputs of similar age from BMC Infectious Diseases
#165
of 197 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,668 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,895 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.